Cell Biology

RSS

UCLA Health Study Identifies Strategy to Boost Strength and Longevity of Cancer Fighting T Cells

Researchers at the UCLA Health Jonsson Comprehensive Cancer Center have identified a promising new strategy to make cancer-fighting immune cells stronger and potentially longer-lasting, a discovery that could help improve the effectiveness of immunotherapies that use a patient's own immune cells to attack cancer.

31 Oct 2026

Science Study Profiles Over 600,000 Cells to Map Gene Activity Across Entire Adult Fish

Viewed from above, Danionella cerebrum offers a rare sight in a vertebrate: its brain, visible through the top of its head. Since the species was adopted for neuroscience research in 2018 and formally described in 2021, the tiny, transparent fish has drawn rapidly growing interest for its unique biology.

31 Oct 2026

Novel Translational Mechanism Selectively Drives Growth Proteins in Common Cancers

A previously unknown mechanism helps cancer cells selectively produce proteins that drive tumor growth - such as KRAS - in common cancers, according to new research from The University of Texas MD Anderson Cancer Center.

30 Oct 2026

Deciphering the Evolutionary Mechanisms Behind High Enzyme Selectivity

Enzymes are the molecular tools of life. They accelerate chemical reactions and are able to distinguish very precisely between molecules that are similar to one another.

30 Oct 2026

Cytosolic Glucose and Mitochondrial Lactate Oxidation Prevent Energetic Collapse

The heart is the hardest-working muscle in the body, beating constantly no matter what the body’s energy reserves look like.

30 Oct 2026

Aberrant RNA Splicing Generates Immunogenic Neoantigens in Systemic Lupus

Scientists at La Jolla Institute for Immunology (LJI) and the University of Washington (UW) have discovered that patients with lupus have unusual mutations that may turn their bodies into battlegrounds.

30 Oct 2026

St. Jude Scientists Discover Gene-Regulatory Pathway Protecting Gut Immune Balance

Trillions of bacteria live in the human gut without triggering an immune response. Scientists at St. Jude Children's Research Hospital have now discovered a gene-regulatory pathway that helps maintain this delicate balance. Published today in Science Advances, they showed that a type of immune cell, regulatory T cells, co-opt a well-known general gene expression pathway called COMPASS to suppress inappropriate immune responses and prevent lethal inflammation and autoimmunity.

30 Oct 2026

Optimizing Laser Pulse Energy for Deep-Brain Imaging Without Tissue Damage

As light travels deeper into the brain, it scatters. Three-photon microscopy, the current state of the art, reduces the resulting background fluorescence and can, in principle, image much deeper than earlier techniques-but to do that, it uses average laser power limits that cause overheating and damage living tissue.

29 Oct 2026

ATCC Selected by ARPA-H to Support Next-Generation BioStabilization Technologies

ATCC has been selected by the Advanced Research Projects Agency for Health (ARPA-H) as an affiliate to provide independent verification and validation (IV&V) for its BioStabilization Systems (BoSS) program.

29 Oct 2026

Science Solves Genetic Mystery Behind Fatal Brain Disorder in Babies and Children

Researchers at King Abdullah University of Science and Technology (KAUST) and King Faisal Specialist Hospital and Research Centre (KFSHRC), identify a previously unknown cause of a fatal newborn brain disorder, giving long-awaited answers to families whose children were affected by the disease.

28 Oct 2026

Switching on Healthy Silent Genes Reveals New Way to Treat Rare Genetic Disorder

WEHI researchers have discovered a way to release a genetic 'brake' that silences healthy genes in Prader-Willi syndrome, opening a potential new path to treating the condition.

27 Oct 2026

Why a Breakthrough Blood Cancer Drug Could be Better for Patients

A more effective and better-tolerated treatment for chronic myeloid leukaemia (CML) could improve quality of life for people living with the disease.

27 Oct 2026

Researchers Develop Predictive Model for Mass Spectrometry Imaging

Andrei Fedorov and his team have found a way to take some of the guesswork out of mass spectrometry imaging (MSI), potentially giving scientists better tools to explore the molecules that influence our health.

27 Oct 2026

PARP1 Disassembles Nucleosomes to Facilitate Essential DNA Damage Repair

When DNA is damaged, cellular processes respond and repair the DNA. Inhibiting DNA damage repair can be therapeutically beneficial in cancers with genetic vulnerabilities related to DNA damage response.

26 Oct 2026

Taurine Deficiency Triggers Innate Immune Sensing of Cellular Danger Signals

Sustained low-level inflammation is a hallmark of the aging process. The accumulating damage persistently activates the innate immune system-the body's first line of defense-leading to what is known as inflammaging, functional decline and chronic diseases of old age.

26 Oct 2026

Squeezing Cell Nuclei Loosens DNA to Boost CRISPR Reprogramming Efficiency

Our cells hold about two meters of DNA, folded and compacted to fit inside a nucleus far narrower than a strand of human hair.

24 Oct 2026

New RNA Extraction Approaches Overcome Agarose Barriers in Lung Slices

Precision-cut lung slices allow researchers to study living human lung tissue outside the body, preserving the different cell types and structures that make up the organ.

24 Oct 2026

Evaxion Announces 89% Vaccine Target Precision and Sustained T-Cell and Clinical Responses at Three-Year Follow-Up in Phase 2 Trial with Personalized Cancer Vaccine EVX-01

Evaxion A/S, a clinical-stage TechBio company developing novel immunotherapies with its pioneering AI-Immunology™ platform, announces new three-year immune and clinical outcome data for personalized cancer vaccine EVX-01 in patients with advanced melanoma.

From Evaxion A/S 24 Oct 2026

INmune Bio Establishes Global Commercialization Framework for Ebstrocel™ Through Strategic Agreement with Uniphar

INmune Bio Inc. (the “Company”), a late-stage biotechnology company focused on inflammation and immunology, today announced that it has entered into a Master Services Agreement with Uniphar Durbin Ireland Limited (“Uniphar”) establishing a scalable framework to support international access, distribution and commercialization of Ebstrocel™, the Company’s allogeneic stromal cell therapy for Recessive Dystrophic Epidermolysis Bullosa (RDEB).

From INmune Bio 22 Oct 2026

Touchlight Announces Leadership Transition, with Will Downie Appointed Interim CEO

Touchlight today announces that Karen Fallen is stepping down as CEO and that the Board of Directors has appointed Will Downie as Interim Chief Executive Officer.

From Touchlight 21 Oct 2026

Cell Biology

UCLA Health Study Identifies Strategy to Boost Strength and Longevity of Cancer Fighting T Cells

Science Study Profiles Over 600,000 Cells to Map Gene Activity Across Entire Adult Fish

Novel Translational Mechanism Selectively Drives Growth Proteins in Common Cancers

Deciphering the Evolutionary Mechanisms Behind High Enzyme Selectivity

Cytosolic Glucose and Mitochondrial Lactate Oxidation Prevent Energetic Collapse

Aberrant RNA Splicing Generates Immunogenic Neoantigens in Systemic Lupus

St. Jude Scientists Discover Gene-Regulatory Pathway Protecting Gut Immune Balance

Optimizing Laser Pulse Energy for Deep-Brain Imaging Without Tissue Damage

ATCC Selected by ARPA-H to Support Next-Generation BioStabilization Technologies

Science Solves Genetic Mystery Behind Fatal Brain Disorder in Babies and Children

Switching on Healthy Silent Genes Reveals New Way to Treat Rare Genetic Disorder

Why a Breakthrough Blood Cancer Drug Could be Better for Patients

Researchers Develop Predictive Model for Mass Spectrometry Imaging

PARP1 Disassembles Nucleosomes to Facilitate Essential DNA Damage Repair

Taurine Deficiency Triggers Innate Immune Sensing of Cellular Danger Signals

Squeezing Cell Nuclei Loosens DNA to Boost CRISPR Reprogramming Efficiency

New RNA Extraction Approaches Overcome Agarose Barriers in Lung Slices

Evaxion Announces 89% Vaccine Target Precision and Sustained T-Cell and Clinical Responses at Three-Year Follow-Up in Phase 2 Trial with Personalized Cancer Vaccine EVX-01

INmune Bio Establishes Global Commercialization Framework for Ebstrocel™ Through Strategic Agreement with Uniphar

Touchlight Announces Leadership Transition, with Will Downie Appointed Interim CEO

The Future of Vision Restoration With ReVision Implant

How a Single List Is Changing Visibility for Women in Science

How Avatar Medical's 3D Technology Is Transforming How We Visualize the Human Body

Editorial Focus eBook - Biopharmaceuticals (2nd edition)

Improving Cell Culture Efficiency with Image-Guided Automation

Improving Scalability in Organoid Research

Cosmetic Formulation and Manufacturing

Latest in Genomics